Results

Total Results: 463 records

Showing results for "renal".

181. Data Points #2: Incidence of diabetic foot ulcer and lower extremity amputation among Medicare beneficiaries, 2006-2008. | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/diabetes-foot-ulcer-amputation-incidence/research
     February 17, 2011 - People with diabetes often experience several associated medical complications, such as renal disease

182. Geographic Variation in Carotid Endarterectomy and Carotid Stenting Among Medicare Beneficiaries, 2003-2006 | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/cardiology-health-outcomes/research
     July 28, 2010 - 290.x, 294.1, and 331.2), diabetes mellitus (code 250), hypertension (codes 401-405 and 437.2), and renal … — 60 418 (90.6) 6820 (92.7) Peripheral vascular disease — 24 625 (36.9) 3386 (46.0) Renal … 1.58 (1.52-1.64) b Previous carotid endarterectomy 1.12 (1.05-1.20) c 3.06 (2.65-3.53) b Renal

183. Diabetes-Foot-Ulcer-Amputation-Prevalence Research (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-foot-ulcer-amputation-prevalence_research.pdf
     February 01, 2011 - Those with diabetes are expected to suffer from several associ- ated medical complications, such as renal … The prevalence of LEA in nonelderly diabetics with PAD (many of whom likely have end-stage renal disease

184. Nonopioid Pharmacologic Treatments for Chronic Pain: Appendix F2 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/nonopioid-chronic-pain-apf2_0.xlsx
     January 01, 2018 - Events CV Events GI GI GI GI Liver Dysfunction Liver Dysfunction Liver Dysfunction Liver Dysfunction Renal … Dysfunction Renal Dysfunction Renal Dysfunction Renal Dysfunction Application Site Reaction (additional … Events CV Events GI GI GI GI Liver Dysfunction Liver Dysfunction Liver Dysfunction Liver Dysfunction Renal … Dysfunction Renal Dysfunction Renal Dysfunction Renal Dysfunction Application Site Reaction (additional

185. Stroke Prevention in Atrial Fibrillation | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/stroke-atrial-fibrillation/research-protocol
     January 30, 2012 - coronary syndrome Subpopulations, including: patients with comorbid conditions, such as dementia, or renal … Food and Drug Administration; HAS-BLED = hypertension, abnormal renal/liver function, stroke, bleeding … Subgroups of potential interest include: Patients who have comorbid conditions such as dementia or renal … Food and Drug Administration GWTG Get With The Guidelines HAS-BLED hypertension, abnormal renal/liver

186. CER 173 Executive Summary: Diabetes Medications for Adults With Type 2 Diabetes: An Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/diabetes-update-2015_executive.pdf
     January 01, 2015 - pressure and heart rate, and for studies that include a comparison with SGLT-2 inhibitors, impaired renal … • We included studies addressing the following safety outcomes for KQ3: – Liver injury – Impaired renal … The exclusion criteria were generally similar for most trials: significant renal, cardiovasular, and … described in prior reviews.18, 68 The evidence on SGLT-2 inhibitor comparisons regarding fractures, renal … Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes

187. Topic Suggestion Description | Effective Health Care Program
     effectivehealthcare.ahrq.gov/get-involved/nominated-topics/key-questions-1-does-routine-preoperative-testing-compared-to-no-testing-or-alternative-testing-strategies-improve-outcomes-such-as-surgical-complications-other-morbidity-and-mortality-among-patients-undergoing-elective-surge
     February 10, 2011 - preoperative evaluation include: complete blood count, electrocardiogram, chest radiograph, electrolytes, renal

188. CER 45 Self-Measured Blood Pressure Monitoring Comparative Effectiveness Surveillance Final 4.7.16 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/measuring-blood-pressure-surveillance-160412.pdf
     April 11, 2016 - Reduced"effect"of"percutaneous" renal"denervation"on"blood"pressure"in"patients"with"isolated"systolic"hypertension … Blood"pressure"changes"after"renal"denervation"at"10"European"expert" centers." … "(2015)."4a.03:"Catheter' Based"Renal"Denervation"for"Resistant"Hypertension:"24"Month"Results"of"the"Enlightn"I … Eligibility"for"percutaneous" renal"denervation:"the"importance"of"a"systematic"screening." … Clinical(Outcomes( SOE:(Insufficient( ( One$quality$C$study$reported$ on$mortality$and$end"stage$ renal

189. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/angina-heart-attack-treatments_research-protocol.pdf
     December 11, 2012 - percent being cleared by the kidneys, and has a plasma half-life of 25 minutes in patients with normal renal … disease:  Subgroups by age, sex, weight, body mass index, diabetes, heart failure, previous stroke, renal … characteristics • Age • Sex • Diabetes • Weight • Body mass index • Heart failure • Previous stroke • Renal … characteristics including age, sex, weight, body mass index, diabetes, heart failure, previous stroke, renal … minutes and then continued at 0.1 mcg/kg/min for 12 to 24 hr following PCI Patients with severe renal

190. Vitamin-D-Calcium-Protocol-130611 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/vitamin-d-calcium_research-protocol.pdf
     September 13, 2013 - cardiovascular diseases, cancer, immune function, pregnancy or birth outcomes, mortality, fracture, renal … Adverse effects of intervention(s)  All-cause mortality  Cancer and cancer-specific mortality  Renal … upper intake levels (ULs/AEs; specifically, all-cause mortality; cancer and cancer-specific mortality, renal

191. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/stroke-atrial-fibrillation_research-protocol.pdf
     January 30, 2012 - coronary syndrome o Subpopulations, including: patients with comorbid conditions, such as dementia, or renal … Subgroups of potential interest include: o Patients who have comorbid conditions such as dementia or renal … Food and Drug Administration; HAS-BLED = hypertension, abnormal renal/liver function, stroke, bleeding … Food and Drug Administration GWTG Get With The Guidelines HAS-BLED hypertension, abnormal renal/liver

192. Methods White Paper: Improving the Utility of Evidence Synthesis for Decision Makers in the Face of Insufficient Evidence (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/improving-utility-evidence-synthesis-white-paper.pdf
     April 01, 2021 - Denervation in the Medicare Population35 What is the evidence for renal denervation effectiveness … Management of Renal Masses and Localized Renal Cancer36 Efficacy and comparative efficacy of different … interventions for the management of a renal mass suspicious for localized renal cell carcinoma … Renal denervation in the medicare population. … Management of renal masses and localized renal cancer: systematic review and meta- analysis.

193. Comparative Effectiveness of Dietary Supplement Versus No Dietary Supplement Use in Adults Taking Cardiovascular Drugs | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/dietary-supplements/research-protocol
     December 21, 2010 - Syncope Quality of life Hospitalization Adherence to prescribed cardiovascular drug regimen Renal … aminotransferase [AST], alanine aminotransferase [ALT], alkaline phosphatase [ALP], or hepatitis) Renal … disease, with known cardiovascular disease; participants with diabetes; participants with hepatic or renal … dysfunction or end-stage renal disease; participants taking a cardiovascular drug for an indication … adverse events, clinical bleeding (intracranial, gastrointestinal, genitourinary, subretinal, etc.), renal

194. Arthritis and Nontraumatic Joint Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1512.pdf
     December 29, 2015 - organic anion transporter involved in controlling the reabsorption of uric acid from the proximal renal … Use of lesinurad alone resulted in more patients experiencing elevated serum creatinine levels and renal … , diarrhea, and nausea.27 Some preliminary evidence suggests lesinurad could increase the risk of renal … However, better gout management could reduce hospitalizations and renal or cardiovascular complications … provide cost offsets from treatment with lesinurad.38,40 Two research experts noted concerns over renal

195. Disposition of Comments Report for Treatment for Hepatitis C Virus Infection in Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c_disposition-comments.pdf
     November 27, 2012 - treatment-naive individuals and does not consider "difficult-to-treat" populations (e.g., HIV- coinfected, renal … Treatment decisions for HIV-coinfected patients and persons with end- stage renal disease might differ … not aware of trials of antiviral treatments that have specifically enrolled patients with end-stage renal … Additional CERs of treatments in HIV-coinfected patients, patients with end-stage renal disease, and … Additional CERs of treatments in HIV-coinfected patients, patients with end-stage renal disease, and

196. Rheumatoid-Arthritis-Medicine Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-medicine_executive.pdf
     April 01, 2012 - Toxicity was more likely with MTX in patients with greater renal impairment. … Those with high- risk comorbidities (cardiovascular events, diabetes, malignancies, renal impairment

197. Comparative Effectiveness of Treatments for Restless Legs Syndrome | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/restless-legs/research-protocol
     December 16, 2011 - to be idiopathic or primary RLS, or secondary to other conditions such as iron deficiency, end-stage renal … characteristics (age, gender, race, comorbidities, disease severity, etiology, iron status, pregnancy, end-stage renal … Studies that include individuals with RLS comorbid with iron deficiency, pregnancy, or end-stage renal

198. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/dietary-supplements_research-protocol.pdf
     December 15, 2010 - Syncope • Quality of life • Hospitalization • Adherence to prescribed cardiovascular drug regimen • Renal … aminotransferase [AST], alanine aminotransferase [ALT], alkaline phosphatase [ALP], or hepatitis) o Renal … disease, with known cardiovascular disease; participants with diabetes; participants with hepatic or renal … dysfunction or end-stage renal disease; participants taking a cardiovascular drug for an indication … adverse events, clinical bleeding (intracranial, gastrointestinal, genitourinary, subretinal, etc.), renal

199. Topic Suggestion Description | Effective Health Care Program
     effectivehealthcare.ahrq.gov/get-involved/nominated-topics/1-what-is-the-etiology-of-acute-and-chronic-urinary-retention-in-adults-2-how-do-we-define-urinary-retention-base-case-including-those-with-known-neurologic-problems-aka-what-is-considered-abnormal-pvr-3-what-is-the-natural-h
     April 22, 2011 - Risk of infection Risk of renal failure, upper urinary tract deterioration, and urosepsis Risk of

200. Executive summary_Comparative Effectiveness Review No. 264_Social and Structural Determinants of Maternal Morbidity and Mortality: An Evidence Map (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-264-maternal-morbidity-mortality-executive-summary.pdf
     December 01, 2023 - by comorbidities (including prepregnancy body mass index, diabetes, hypertension, cardiac disease, renal